V-Guard Ind Standalone September 2019 Net Sales at Rs 619.31 crore, up 3.64% Y-o-Y
November 07, 2019 / 12:00 PM IST
Reported Standalone quarterly numbers for V-Guard Industries are:Net Sales at Rs 619.31 crore in September 2019 up 3.64% from Rs. 597.58 crore in September 2018.
Quarterly Net Profit at Rs. 57.32 crore in September 2019 up 50.11% from Rs. 38.18 crore in September 2018.
EBITDA stands at Rs. 84.48 crore in September 2019 up 57.11% from Rs. 53.77 crore in September 2018.
V-Guard Ind EPS has increased to Rs. 1.34 in September 2019 from Rs. 0.90 in September 2018.
V-Guard Ind shares closed at 243.50 on November 06, 2019 (NSE) and has given 14.35% returns over the last 6 months and 24.14% over the last 12 months.
| V-Guard Industries | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'19 | Jun'19 | Sep'18 | | Net Sales/Income from operations | 619.31 | 699.39 | 597.58 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 619.31 | 699.39 | 597.58 | | EXPENDITURE | | Consumption of Raw Materials | 197.33 | 164.85 | 192.11 | | Purchase of Traded Goods | 256.53 | 244.75 | 238.43 | | Increase/Decrease in Stocks | -43.70 | 62.11 | -9.98 | | Power & Fuel | -- | -- | -- | | Employees Cost | 45.02 | 60.23 | 50.58 | | Depreciation | 6.93 | 6.74 | 5.46 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 86.56 | 96.32 | 76.59 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 70.64 | 64.38 | 44.39 | | Other Income | 6.91 | 6.45 | 3.92 | | P/L Before Int., Excpt. Items & Tax | 77.55 | 70.83 | 48.31 | | Interest | 0.83 | 1.06 | 0.27 | | P/L Before Exceptional Items & Tax | 76.72 | 69.77 | 48.04 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 76.72 | 69.77 | 48.04 | | Tax | 19.40 | 17.32 | 9.86 | | P/L After Tax from Ordinary Activities | 57.32 | 52.45 | 38.18 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 57.32 | 52.45 | 38.18 | | Equity Share Capital | 42.75 | 42.71 | 42.64 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.34 | 1.23 | 0.90 | | Diluted EPS | 1.32 | 1.21 | 0.88 | | EPS After Extra Ordinary | | Basic EPS | 1.34 | 1.23 | 0.90 | | Diluted EPS | 1.32 | 1.21 | 0.88 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
NBFC licence, startup ambitions: At 70, Kerala’s most famous billionaire is planning his next big moves Watch more 
Covaxin phase 3 trials efficacy at 81%, says Bharat Biotech Watch more 
What a rise in US bond yields mean for investors and Indian equities Watch more 
Ideas For Profit | MTAR Technologies IPO: Should you add this stock to your portfolio? Watch more 
